CDB25:0004327 ST6GAL1 — EGFR

Experimentally validated in Human; Orthology-inferred in Mouse, Rat, Frog, Zebrafish, Chicken, Macaque, Pig, Dog, Cow, Chimp, Horse, Marmoset, Sheep

Title

Journal:; Year Published:

Abstract

Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death.

Journal of ovarian research, 2018; PubMed, Homo sapiens ST6GAL1 — Homo sapiens EGFR
ABSTRACT: The ST6Gal-I sialyltransferase is upregulated in numerous cancers, and high expression of this enzyme correlates with poor patient prognosis in various malignancies, including ovarian cancer. Through its sialylation of a select cohort of cell surface receptors, ST6Gal-I modulates cell signaling to promote tumor cell survival. The goal of the present study was to investigate the influence of ST6Gal-I on another important receptor that controls cancer cell behavior, EGFR. Additionally, the effect of ST6Gal-I on cancer cells treated with the common EGFR inhibitor, gefitinib, was evaluated.
Basic Information on ST6GAL1
Ligand Name: ST6 beta-galactoside alpha-2,6-sialyltransferase 1
Other Symbols: SIAT1, CDw75
Ligand Location: secreted based on perplexity, uniprot
HGNC Gene Symbol Report: ST6GAL1
GeneCards: ST6GAL1
HGNC Gene Group: Glycosyltransferases
Interactions with other Receptors for ST6GAL1
Basic Information on EGFR
Receptor Name: epidermal growth factor receptor
Other Symbols: ERBB, ERBB1, ERRP
Receptor Location: cell membrane based on hpa, perplexity, uniprot
HGNC Gene Symbol Report: EGFR
GeneCards: EGFR
HGNC Gene Group: Receptor kinases